Scientists produce potential Alzheimer’s disease treatment of the cocktail variety
Contemporary Long-Term Care Weekly, January 14, 2010
A nutritional cocktail, called Souvenaid, is believed to help restore the synapses (the junctions between neurons or between a neuron and muscle) in a person’s brain. The recent development could prove to be extremely beneficial to people suffering from Alzheimer’s disease or dementia, as research shows a correlation between low numbers of synapses and memory impairment, according to CNN.
The drink, known as a "medicinal food" because it is authorized by a physician and is intended to affect a specific condition, contains uridine, choline, and the omega-3 fatty acid DHA. All three nutrients already exist in the human body, but it is their interaction in the correct proportions that’s believed to produce the proteins required for the restoration of synapses, based on the study co-authored by Dr. Richard Wurtman of the Massachusetts Institute of Technology. Future clinical studies involving Souvenaid and Alzheimer’s patients are planned to gain a better understanding of the cocktail’s capabilities.
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- HIPAA Q&A: Level of encryption needed for email
- Searched
